We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
51.91%
This Fund
S&P 500
This Quarter
Est. Return
+36.71%
1 Year Est. Return
+51.91%
3 Year Est. Return
+141.83%
5 Year Est. Return
+190.65%
10 Year Est. Return
+820.86%
AUM
$67.7B
AUM Growth
-$232B
(-77%)
Cap. Flow
-$239B
Cap. Flow
% of AUM
-353.77%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
1,768
New
198
Increased
778
Reduced
622
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$4.43B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$714M |
| 3 |
TSMC
TSM
|
+$391M |
| 4 |
ASML
ASML
|
+$273M |
| 5 |
NVIDIA
NVDA
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$265B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$641M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$51M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$50.1M |
| 5 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.79% |
| 2 | Industrials | 11.26% |
| 3 | Communication Services | 6.36% |
| 4 | Consumer Discretionary | 5.41% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
AngloGold Ashanti
AU
$40.7B
| $91.7K | ﹤0.01% |
1,134
-281
| -20% | -$26.7K |
|
1252
Monte Rosa Therapeutics
GLUE
$1.91B
| $91.4K | ﹤0.01% |
3,778
-199
| -5% | -$3.76K |
|
1253
Stoke Therapeutics
STOK
$1.83B
| $91.1K | ﹤0.01% |
2,785
-194
| -7% | -$6.23K |
|
1254
Match Group
MTCH
$9.05B
| $91.1K | ﹤0.01% |
2,393
+186
| +8% | +$6.59K |
|
1255
Precigen
PGEN
$1.93B
| $90.9K | ﹤0.01% |
15,944
-2,511
| -14% | -$10.9K |
|
1256
Lyft
LYFT
$5.73B
| $90.5K | ﹤0.01% |
6,192
+2,186
| +55% | +$30.6K |
|
1257
Amylyx Pharmaceuticals
AMLX
$2.17B
| $89.3K | ﹤0.01% |
4,973
-755
| -13% | -$11.7K |
|
|
RAPP
1258
Rapport Therapeutics
RAPP
$2.01B
| $89.1K | ﹤0.01% |
2,139
-347
| -14% | -$12.8K |
|
|
SION
1259
Sionna Therapeutics
SION
$2.05B
| $88.8K | ﹤0.01% |
2,019
-309
| -13% | -$12.4K |
|
1260
AnaptysBio
ANAB
$1.59B
| $87.8K | ﹤0.01% |
1,301
-143
| -10% | -$8.67K |
|
1261
Taysha Gene Therapies
TSHA
$1.59B
| $87.5K | ﹤0.01% |
12,852
-1,435
| -10% | -$8.49K |
|
|
BCAX
1262
Bicara Therapeutics
BCAX
$1.83B
| $87.3K | ﹤0.01% |
2,939
-366
| -11% | -$8.17K |
|
1263
Teladoc Health
TDOC
$1.61B
| $87.1K | ﹤0.01% |
+10,271
| New | +$68.3K |
|
1264
AtaiBeckley Inc
ATAI
$2.65B
| $86.8K | ﹤0.01% |
16,466
-2,479
| -13% | -$10.4K |
|
1265
ADMA Biologics
ADMA
$1.97B
| $86.8K | ﹤0.01% |
10,366
-2,177
| -17% | -$19.8K |
|
1266
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$223M
| $86.7K | ﹤0.01% |
10,000
-25,900
| -72% | -$232K |
|
1267
Syndax Pharmaceuticals
SNDX
$1.82B
| $86.6K | ﹤0.01% |
3,963
-637
| -14% | -$13.2K |
|
1268
Recursion Pharmaceuticals
RXRX
$1.6B
| $86.1K | ﹤0.01% |
23,466
-3,759
| -14% | -$12.5K |
|
1269
Monro
MNRO
$529M
| $85.5K | ﹤0.01% |
+5,000
| New | +$81.8K |
|
1270
Zymeworks
ZYME
$1.69B
| $85.4K | ﹤0.01% |
3,266
-637
| -16% | -$16.2K |
|
1271
Tyra Biosciences
TYRA
$1.85B
| $85K | ﹤0.01% |
2,660
-124
| -4% | -$4.1K |
|
1272
Sarepta Therapeutics
SRPT
$1.68B
| $84.9K | ﹤0.01% |
4,722
-744
| -14% | -$14.1K |
|
1273
Maplebear
CART
$10.4B
| $84.7K | ﹤0.01% |
1,789
+339
| +23% | +$14.2K |
|
1274
StepStone Group
STEP
$3.65B
| $84.4K | ﹤0.01% |
+2,040
| New | +$101K |
|
|
CMPS
1275
Compass Pathways
CMPS
$1.52B
| $84.2K | ﹤0.01% |
5,953
+1,034
| +21% | +$10.5K |
|
Similar funds
Mirae Asset Global Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Mirae Asset Global Investments held 1,768 positions worth $67.7B, down 77% from $299B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Mirae Asset Global Investments withdrew a net $239B in Q2 2026, closing 98 positions and reducing 622 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $265B position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 4.1% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Mirae Asset Global Investments opened a new position in SpaceX worth $4.45B.
- Mirae Asset Global Investments's largest Q2 2026 buy was SpaceX: 26,056,048 shares worth $4.45B.
- Mirae Asset Global Investments added most to Alphabet (Google) Class C in Q2 2026, an estimated $714M increase.
- Mirae Asset Global Investments's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $641M.
- Mirae Asset Global Investments fully exited Berkshire Hathaway Class A in Q2 2026, selling an estimated $265B.
- Mirae Asset Global Investments's ten largest holdings make up 50% of its $67.7B portfolio in Q2 2026.
- Mirae Asset Global Investments opened 198 new positions and closed 98 in Q2 2026.
- Mirae Asset Global Investments's portfolio value fell 77% quarter-over-quarter to $67.7B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.